The use of RMI in triaging benign pelvic masses from malignant lesions and facilitating their management

Authors

  • Kranti Kulkarni Department of Obstetrics and Gynaecology, PGIMS, Navi Mumbai, Maharashtra, India
  • Amit Phadnis Department of General Surgery, Terna Medical College, Navi Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20250851

Keywords:

Abdominal lump, Pelvic mass, Malignancy index, Gynaecological tumors, Adnexal mass, Ovarian tumour

Abstract

Background: The most prevalent type of pelvic masses presenting to Gynec OPD are ovarian masses, which include cysts and tumors. Ovarian cancer is more common in older women, with highest incidence in seventies. Ultrasonography and surgically obtained tissue for diagnosis helps in optimising final plan. Good ethical practices suggest involvement of Gynec Oncosurgeon whenever necessary, after a correct preoperative diagnosis of pelvic masses is made. The basic diagnostic work-up of patients with a pelvic mass consists of a gynaecological examination, ultrasound and the analysis of serum tumour markers, especially CA 125. The objective of this study is to triage the patients and ensure optimum therapeutic approach for commonly encountered gynecological pelvic masses and to provide protocol-based treatment

Methods: Ours was a multicentric cross-sectional study in Navi Mumbai on “Patients presenting with abdominal masses” a combined, retrospective as well as prospective during the period of 6 months. 1st January 2023- 30th June 2023.

Results: The study group comprising of 140 patients in all, from 3 centres, were followed up from diagnosis till treatment comprising of namely: Gynec OPD at General hospital (10), a private MRI centre (30) and those admitted/attending Gynec OPD in Oncology hospital (100) with sonography findings of a pelvic mass greater than 6 cm size. Authors evaluated them on the basis of age, symptoms, and examination and tumor markers and managed as per RMI score to set a protocol.

Conclusions: With the help of ultrasonography findings and Ca125, the risk of malignancy index was calculated and helped us differentiate benign masses from cytology proven malignancy.

Metrics

Metrics Loading ...

References

Karimi-Zarchi M, Mojaver SP, Rouhi M, Hekmatimoghaddam SH, Moghaddam RN, Yazdian-Anari P, et al. Diagnostic value of the risk of malignancy index (RMI) for detection of pelvic malignancies compared with pathology. Electronic Phys. 2015;7(7):1505. DOI: https://doi.org/10.19082/1505

Timmerman D, Calster BV. Predicting the risk of malignancy in adnexal masses based on the simple rules from the international ovarian tumor analysis group. AJOG. 2016;1:7. DOI: https://doi.org/10.1016/j.ajog.2016.01.007

Cherukuri S, Jajoo S, Dewani D, Cherkri S. The International ovarian tumor analysis-assessment of different neoplasia in the adnexa (IOTA-ADNEX) model assessment for risk of ovarian malignancy in adnexal masses. Cureus. 2022;14(11):56. DOI: https://doi.org/10.7759/cureus.31194

Mohan S, Kapoor G, Nagpal PK, Aggarwal R, Gami N. Managing adnexal masses: a medical quandary. JCDR. 2013;7(9):1971. DOI: https://doi.org/10.7860/JCDR/2013/6243.3372

Abdulrahman GO, McKnight L, Singh KL. The risk of malignancy index (RMI) in women with adnexal masses in Wales. Taiwanese J Obst Gynecol. 2014;53(3):376-81. DOI: https://doi.org/10.1016/j.tjog.2014.05.002

Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. BJOG. 1990;97(10):922-9. DOI: https://doi.org/10.1111/j.1471-0528.1990.tb02448.x

Aktürk E, Karaca RE, Alanbay İ, Dede M, Karaşahin E, Yenen MC, Başer İ. Comparison of four malignancy risk indices in the detection of malignant ovarian masses. Journal of gynecologic oncology. 2011;22(3):177. DOI: https://doi.org/10.3802/jgo.2011.22.3.177

Huwidi A, Abobrege A, Assidi M, Buhmeida A, Ermiah E. Diagnostic value of risk of malignancy index in the clinical evaluation of ovarian mass. Molecu and Clin Oncol. 2022;17(1):118. DOI: https://doi.org/10.3892/mco.2022.2551

Hada A, Han LP, Chen Y, Hu QH, Yuan Y, Liu L. Comparison of the predictive performance of risk of malignancy indexes 1–4, HE4 and risk of malignancy algorithm in the triage of adnexal masses. J of Ovar Research. 2020;13:1-9. DOI: https://doi.org/10.1186/s13048-020-00643-6

Engelen MJ, Bongaerts AH, Sluiter WJ, De Haan HH, Bogchelman DH, TenVergert EM, et al. Distinguishing benign and malignant pelvic masses: The value of different diagnostic methods in everyday clinical practice. European J of Obst & Gynecol and Reprod Biol. 2008;136(1):94-101. DOI: https://doi.org/10.1016/j.ejogrb.2006.10.004

Downloads

Published

2025-03-27

How to Cite

Kulkarni, K., & Phadnis, A. (2025). The use of RMI in triaging benign pelvic masses from malignant lesions and facilitating their management. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 14(4), 1133–1139. https://doi.org/10.18203/2320-1770.ijrcog20250851

Issue

Section

Original Research Articles